Answers are grounded in this paper and cite their sources.
Imidazo[1,2-a]pyridine exerts a notable pharmacological efficiency and has emerged as an integral backbone for the treatment of various cancer.Inhibition of cyclin-dependent kinases has emerged as a potential therapeutic strategy for a variety of cancers.Here, we discuss the synthesis of imidazo[1,2-a]pyridine derivatives modified at positions 6 and 8 prepared using Suzuki-Miyaura crosscoupling, Buchwald reaction, and peptide coupling as the main synthetic methods.All synthesized compounds were characterized by spectroscopy techniques after purification and screened for their anti-cancer activity by in vitro MTT assays against MCF-T cell line and CDK2 inhibition by kinase inhibition assay.The in vitro and kinase inhibition assay revealed that compounds 11ii, 11iii, 11xxi, 11vi, and 11viii show potent anti-cancer activity for the treatment of breast cancer.This study demonstrates that substituted imidazo[1,2-a]pyridine can be exploited for future cyclin-dependent kinase (CDK2) inhibitor development.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: